⌘K

17:00:08·23d

SECFilingvia Quantisnow

Adial Pharmaceuticals Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.

ADIL· Adial Pharmaceuticals Inc

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

ADIL
Adial Pharmaceuticals Inc
Health Care

Recent analyst ratings

Nov 14UpdateRodman & Renshaw$8.00
Oct 13UpdateBrookline Capital$12.00
Jun 29UpdateLitchfield Hills$5.00

Related

PR3d
Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045
PR5d
Adial Pharmaceuticals Submits Application to FDA Commissioner's National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program
PR10d
Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial
INSIDER23d
SEC Form 4 filed by Anderson J. Kermit
INSIDER23d
SEC Form 4 filed by Goodman Tony
INSIDER23d
SEC Form 4 filed by Shah Vinay
INSIDER23d
SEC Form 4 filed by Schuyler Kevin
INSIDER23d
SEC Form 4 filed by Claiborne Cary J